ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 89 filers reported holding ENZO BIOCHEM INC in Q4 2015. The put-call ratio across all filers is 1.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $0 | – | 24 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 24 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 24 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 24 | -97.9% | 0.00% | -100.0% |
| Q4 2018 | $3,000 | -25.0% | 1,158 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $4,000 | -33.3% | 1,158 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $6,000 | 0.0% | 1,158 | 0.0% | 0.00% | +50.0% |
| Q1 2018 | $6,000 | -33.3% | 1,158 | 0.0% | 0.00% | -50.0% |
| Q4 2017 | $9,000 | -25.0% | 1,158 | 0.0% | 0.00% | -42.9% |
| Q3 2017 | $12,000 | -14.3% | 1,158 | -13.8% | 0.01% | -12.5% |
| Q2 2017 | $14,000 | +7.7% | 1,343 | -17.6% | 0.01% | +14.3% |
| Q1 2017 | $13,000 | +18.2% | 1,630 | 0.0% | 0.01% | +16.7% |
| Q4 2016 | $11,000 | +37.5% | 1,630 | 0.0% | 0.01% | +20.0% |
| Q3 2016 | $8,000 | -11.1% | 1,630 | +1.5% | 0.01% | 0.0% |
| Q2 2016 | $9,000 | +28.6% | 1,606 | 0.0% | 0.01% | +25.0% |
| Q1 2016 | $7,000 | 0.0% | 1,606 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $7,000 | – | 1,606 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBERT FUND ADVISORS, INC. | 5,169,337 | $17,420,000 | 25.49% |
| Roumell Asset Management, LLC | 1,236,309 | $4,166,000 | 9.86% |
| Evermore Global Advisors, LLC | 3,587,251 | $12,089,000 | 2.28% |
| CORRADO ADVISORS, LLC | 198,544 | $669,000 | 0.60% |
| Fondren Management LP | 175,863 | $593,000 | 0.56% |
| MARATHON CAPITAL MANAGEMENT | 247,130 | $832,000 | 0.34% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $322,000 | 0.21% |
| EAM Investors, LLC | 178,939 | $603,000 | 0.15% |
| Leap Investments LP | 11,811 | $40,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 75,900 | $256,000 | 0.03% |